Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endothelium and hemorrhages]

C Mazurier1, J Goudemand

  • 1Laboratoire de recherche sur l'hémostase, Lille.

La Revue Du Praticien
|June 9, 1998
PubMed
Summary

Von Willebrand factor is crucial for blood clotting and preventing bleeding disorders. Advances in understanding this protein have improved diagnosis and treatment for von Willebrand disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Costs and management of patients with hemophilia A in France: the Hemraude study.

The European journal of health economics : HEPAC : health economics in prevention and care·2021
Same author

Coagulation standards in healthy newborns and infants.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
Same author

Fifth Åland Island conference on von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

New findings on inhibitor development: from registries to clinical studies.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Response to Wiewel-Verschueren S et al.: gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

A novel micronucleus in vitro assay utilizing human hematopoietic stem cells.

Toxicology in vitro : an international journal published in association with BIBRA·2015

Area of Science:

  • Hematology
  • Biochemistry
  • Molecular Biology

Context:

  • Von Willebrand factor (VWF) is essential for primary hemostasis.
  • VWF mediates platelet adhesion and aggregation at vascular injury sites.
  • VWF functions as a carrier protein for coagulation factor VIII.

Purpose:

  • To summarize recent advancements in understanding VWF.
  • To highlight the impact of this knowledge on von Willebrand disease (VWD) diagnosis and treatment.

Summary:

  • Normal endothelium and megakaryocytes synthesize and secrete VWF.
  • Quantitative or qualitative VWF defects cause von Willebrand disease, the most common inherited bleeding disorder.
  • Recent progress has elucidated VWF's synthesis, structure, and function.

Impact:

  • Improved diagnostic strategies for various VWD molecular forms.
  • Enhanced therapeutic approaches for patients with VWD.
  • Better understanding of hemostasis and thrombosis mechanisms.

Related Experiment Videos